Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

GNOM

Global X Genomics & Biotechnology ETF

Apr 24 • 11:45AM ET

46.34

+0.18 0.39 %

Financial • Exchange Traded Fund • USA • NASD

Category	Global or ExUS Equities - Industry Sector	Asset Type	Equities (Stocks)	Tags	Global	Return% 1Y	48.47%	Total Holdings	51	Perf Week	-2.01%
Sponsor	Global X	ETF Type		Tags	equity	Return% 3Y	-2.15%	AUM	51.98M	Perf Month	5.38%
Fund Family		Bond Type		Tags	healthcare	Return% 5Y	-12.10%	NAV/sh		Perf Quarter	-6.39%
Index	Solactive Genomics Index	Average Maturity		Tags	biotechnology	Return% 10Y		52W High	51.42 -9.88%	Perf Half Y	7.86%
Index Weighting		Commodity Type		Tags	genomics	Return% SI		52W Low	29.44 57.40%	Perf YTD	1.94%
Active/Passive		Quant Type		Tags	-	Flows% 1M	-1.57%	Volatility	1.69% 1.91%	Perf Year	41.45%
Dividend TTM	0.62 (1.35%)	ESG Type		Tags	-	Flows% 3M	2.59%	ATR (14)	1.02	Perf 3Y	-7.01%
Dividend Ex-Date	Dec 30, 2025	Dividend Type		Sector/Theme		Flows% YTD	-1.15%	RSI (14)	54.59	Perf 5Y	-49.17%
Dividend Gr. 3/5Y	- -	Structure Type		Region		Flows% 1Y		Beta	1.22	Perf 10Y	-
Expense	0.50%	Growth/Value		SMA20	2.61%	Flows% 3Y		Rel Volume	1.04	Prev Close	46.16
Inverse/Leveraged		Market Cap		SMA50	2.40%	Flows% 5Y		Avg Volume	8.33K	Price	46.34
IPO	Apr 10, 2019	Option/Short	Yes / Yes	SMA200	8.47%	Trades		Volume	3,277	Change	0.39%

Jun-20-25 11:56AM	Gene Therapy Stocks Fall as FDA Pushes Out Another Top Regulator (Barrons.com)
11:56AM	Gene Therapy Stocks Fall Amid More Turmoil at FDA (Barrons.com)
May-02-25 03:25AM	Aim To Keep Risk Modest And Quality High (Seeking Alpha)
Apr-30-25 04:35AM	3 Ways To Avoid The Eye Of The Equity Market Storm (Seeking Alpha)
Apr-24-25 07:14AM	The Next Big Theme: April 2025 (Seeking Alpha)
07:14AM	Loading…
07:14AM	Inflection Points: Roll With The Changes (Seeking Alpha)
Apr-23-25 05:45AM	Rewiring Global Trade For Resilience And Growth (Seeking Alpha)
Apr-20-25 11:28AM	IDNA: The Cutting Edge Of Medical Science Is A Risky Investment (Seeking Alpha)
Apr-18-25 01:40PM	Institutional, Retail Investors Shed $27B In U.S. Stocks In Early April Sell-Off (Seeking Alpha)
Apr-04-25 08:30AM	How Will New Tariffs Impact Your Investment Portfolio In 2025? (Seeking Alpha) -5.08%
Apr-02-25 07:00AM	The Great Transformation: Riding The Wave Of Change (Seeking Alpha)
Apr-01-25 05:40AM	U.S. Consumers To Be Hit Hardest By Pharmaceutical Tariffs (Seeking Alpha)
Mar-28-25 06:05AM	Volatility Brings Changes To Market Leadership (Seeking Alpha)
Mar-20-25 04:32PM	How ESG Policies Can Keep The Healthcare Sector Fighting Fit (SeekingAlpha)
Mar-19-25 03:52PM	The Next Big Theme: March 2025 (SeekingAlpha)
01:38PM	Loading…
Jan-26-22 01:38PM	Sightline Wealth Advisors, LLC Buys iShares 0-5 Year TIPS Bond ETF, ARK Genomic Revolution ETF, ... (GuruFocus.com)
Jan-20-22 09:38AM	Archford Capital Strategies, LLC Buys iShares Short Treasury Bond ETF, Global X Autonomous ... (GuruFocus.com)
Jan-13-22 01:38PM	McGuire Investment Group, LLC Buys SPDR Bloomberg 1-3 Month T-Bill ETF, WisdomTree Floating ... (GuruFocus.com)
Nov-25-20 03:37PM	ETF Wrap: A very ETF Thanksgiving, and tax season too (MarketWatch)
Aug-27-20 05:31PM	This High-Growth Tech Stock Play Is Up 96% As Cloud Computing Stocks Push Higher (Investor's Business Daily)
Jun-08-20 04:00AM	Thematic ETFs The New Sectors? (ETF.com)
Jun-04-20 12:20PM	ETFs Under $20 From 5 Hottest Zones (Zacks)
May-26-20 12:50PM	3 Genomics ETFs Worth Jumping For (Benzinga)
07:40AM	Genomics ETF (GNOM) Hits New 52-Week High (Zacks)
Jan-09-20 11:13AM	Why This Thematic Healthcare Could be a January Winner (ETF Trends)
Dec-26-19 02:30PM	4 Sector ETFs That Beat the Market in Q4 (Zacks)
Dec-18-19 01:41PM	Best & Worst Monthly Performers: December 18 Edition (ETF Database)
Dec-12-19 08:00AM	Beyond Biotech, 5 ETFs Up At Least 10% in Q4 (Zacks)
Dec-04-19 10:23PM	Hedge Funds Have Never Been This Bullish On PTC Therapeutics, Inc. (PTCT) (Insider Monkey)
Nov-29-19 12:15PM	Biotech Tops in November: Best ETFs & Stocks (Zacks)
06:55PM	Loading…
Nov-25-19 06:55PM	Genomics ETFs Surge on CRISPR's Gene Editing Progress (Zacks)
Nov-21-19 12:15PM	Healthcare Sector Outperforming: 5 Best ETFs & Stocks QTD (Zacks)
Oct-30-19 10:43AM	Healthcare ETFs Win in October: Here's Why (Zacks)
Oct-10-19 09:25AM	This High Growth ETF May Not Be As Pricey As You Think (Benzinga)
Sep-06-19 03:07PM	ETFs Poised to Benefit from Gene Editing Revolution (Zacks)
11:09AM	A Young Biotech ETF With Plenty of Potential (ETF Trends)
Sep-04-19 03:18PM	ETFs to Gain From the Booming Genomics Market (Zacks)
Aug-05-19 12:00PM	7 Biotech ETFs That Should Remain Healthy (InvestorPlace)
Aug-01-19 12:10PM	Inside the Allure of a Genomics ETF (ETF Trends)
Jun-24-19 12:17PM	A New ETF For Hot Corners of The Biotech Market (ETF Trends)
Jun-19-19 11:15AM	Wall Street on Pace for Best June in Decades: 5 Best ETFs (Zacks)
Apr-15-19 02:00PM	Four Companies Could Power The New Genomics ETF (ETF Trends)
Apr-11-19 02:18PM	A New Biotech ETF For an Exciting Theme (ETF Trends)
Apr-10-19 08:01AM	Get In On Genomics With This New ETF (Benzinga)
Apr-09-19 05:15PM	Global X Debuts Pure Play Genomics ETF GNOM (ETF Trends)
10:03AM	Global X Launches GNOM: An ETF targeting the Transformative Genomics Industry (PR Newswire)

Global X Genomics & Biotechnology ETF seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Solactive Genomics Index ("underlying index"). The fund invests at least 80% of its total assets in the securities of the underlying index. The underlying index is designed to provide exposure to exchange-listed companies that are positioned to benefit from further advances in the field of genomic science and biotechnology, as well as applications thereof (collectively, "Genomics & Biotechnology Companies"), as defined by Solactive AG, the provider of the underlying index. The fund is non-diversified.

open in yahoo | open in marketwatch | open in google | open in EDGAR

GNOM

Global X Genomics & Biotechnology ETF

Upgrade your Finviz experience